Health Care/Hospital
Antengene Announces Acceptance of IND Application in China for ATG-010 (selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study
SHANGHAI and HONG KONG, Dec. 7, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and on...
2020-12-07 08:00
3490
CARsgen Therapeutics Presents Updated Multiple Myeloma Cell Therapy Data at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition
SHANGHAI, Dec. 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage biopharmaceutical company, announced updated safety and efficacy results from its ongoing global clinical studies of CT053, an investigational chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed an...
2020-12-06 19:00
3533
Gracell Biotechnologies Announces Presentation of First-in-Human Data of GC012F a First-in-Class FasTCAR-enabled Dual-targeting BCMA/CD19 CAR-T Cell Therapy for Patients with Relapsed or Refractory Multiple Myeloma at 2020 ASH Annual Meeting
SUZHOU and SHANGHAI, China, Dec. 5, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced an interim readout to evaluat...
2020-12-06 04:30
3238
Issuance of new shares in Mentice AB (publ) has been registered with the Swedish Companies Registration Office
STOCKHOLM, Dec. 5, 2020 /PRNewswire/ -- Regarding the acquisition of the assets from Vascular Simulations Inc 571,974 shares have been issued at a subscription price ofSEK 86.16 and regarding the acquisition of the assets from EQIP Inc, 9,469 shares have been issued at a subscription price ofSEK ...
2020-12-05 00:35
5387
I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China
SHANGHAI and GAITHERSBURG, Md., Dec. 4, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced the advancement of clinical dev...
2020-12-04 21:00
8211
Samsung Biologics drives digital transformation with Plant 4 Virtual Showroom launch
INCHEON, South Korea, Dec. 4, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced the launch of a virtual showroom to provide key features and real-time construction updates of its recently announced Plant 4. The digital showcase also highlights various specs and services that the S...
2020-12-04 20:00
2192
Indonesia's Government to Continue Improving Competitiveness in Human Capital Against the Backdrop of the Fourth Industrial Revolution and the Demographic Dividend
JAKARTA, Indonesia, Dec. 4, 2020 /PRNewswire/ -- In addition to accelerating national economic recovery in the midst of the Covid-19 pandemic,Indonesia's government continues to support efforts in improving human capital competitiveness. This is done in order to better prepare them in facing the ...
2020-12-04 17:01
2098
Polygiene and Eye-care innovator Body Doctor now increase the range of soothing eye compresses and face masks
STOCKHOLM, Dec. 4, 2020 /PRNewswire/ -- Body Doctor specializes in eye-care, eyelid hygiene products and have transformed the market for eye compresses and continue establishing a pedigree of bringing innovation to the sector with an antibacterial fabric thanks to the partnership with Polygiene®....
2020-12-04 16:23
2423
Ascentage Pharma Appoints Mr. Gang Zhu as Chief Commercial Officer to Lead Commercial Initiatives
SUZHOU, China and ROCKVILLE, Md., Dec. 4, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the appointment of Mr. Gang Z...
2020-12-04 08:28
2293
Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab) is Safe and Well Tolerated in Phase IIa HBV Study
HANGZHOU and SHAOXING, China, Dec. 4, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) announces today that Phase IIa data demonstrated that ASC22 (Envafolimab) is safe and well tolerated in chronic hepatitis B (CHB) patients and Phase IIb clinical trial has been initiated. ASC22 (Envafolima...
2020-12-04 08:00
3433
I Peace, Inc. Obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use
PALO ALTO, Calif., Dec. 3, 2020 /PRNewswire/ -- I Peace, Inc., a Palo Alto -based biotech start-up focusing on Nobel Prize-winning induced pluripotent stem cell (iPSC) technology obtains approval from an independent Institutional Review Board (IRB) for the process of generating iPSCs—including...
2020-12-04 05:00
1187
Aspect Imaging Lauded by Frost & Sullivan for Its Revolutionary Embrace® Neonatal MRI System that Addresses the Key Medical Imaging Challenges of Neonatologists
By eliminating the need to move neonates from the NICU to the radiology department, Aspect Imaging's Embrace enables a safer way to perform the MRI procedure LONDON, Dec. 3, 2020 /PRNewswire/ -- Based on its recent analysis of the global neonatal intensive care unit magnetic resonance imaging (I...
2020-12-03 23:40
1882
Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for COVID-19
Highlights: * The first hospitalized patient with severe COVID-19, treated under an eIND was discharged in 5 days after being treated with Silmitasertib. * The first patient with moderate COVID-19 has enrolled into this clinical trial at the Center for Advanced Research and Education (CARE),G...
2020-12-03 22:17
2215
Drawbridge Health partners with University of Cambridge Researchers for use of OneDraw™ Blood Collection Device in COVID-19 and Other Clinical Studies
MENLO PARK, Calif., Dec. 3, 2020 /PRNewswire/ -- Drawbridge Health and the Medical Research Council (MRC) Epidemiology Unit,University of Cambridge (UK) today announced the use of the OneDraw™ Blood Collection Device1 for remote blood sample collection in a large-scale surveillance study currentl...
2020-12-03 22:00
2178
VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors
AUSTIN, Texas, Dec. 3, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced today the...
2020-12-03 21:30
9819
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A.
Partnership with leading global plasmid manufacturer advances INOVIO's INO-4800 Kaneka Eurogentec to support production of INO-4800 PLYMOUTH MEETING, Pa., Dec. 3, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to ...
2020-12-03 21:00
5487
Antengene Submits NDAs for XPOVIO® (Selinexor) in Multiple APAC Markets for rrMM and rrDLBCL
SHANGHAI and HONG KONG, Dec. 3, 2020 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncolo...
2020-12-03 20:00
5653
Seegene's COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
SEOUL, South Korea, Dec. 3, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Thursday that the extraction-free application of Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is now available inEurope. Previously in September, Se...
2020-12-03 16:23
1171
China Soong Ching Ling Foundation, Erdos Resources Co., Ltd launch specific fund to care for children of deceased COVID-19 fight heroes
ERDOS, China, Dec. 3, 2020 /PRNewswire/ -- On December 2, the launching ceremony of "Warm Erdos Special Fund" of China Soong Ching Ling Foundation was held in the former residence ofSoong Ching Ling, who was a former honorary president ofChina and the wife of Chinese revolutionary Dr. Sun Yat-sen...
2020-12-03 16:06
1384
Forbes Travel Guide and Sharecare issue world's first health security verifications to hotels and resorts across 12 countries
Health security "seal of approval" identifies properties that have achieved verification, establishes confidence with guests and travel planners ATLANTA, Dec. 3, 2020 /PRNewswire/ -- Forbes Travel Guide ("FTG"), the global authority on genuine Five-Star service, andSharecare, the digital health ...
2020-12-03 15:00
2525
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9198
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7771
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5194
